Filing Fee Exhibit

Ex-Filing Fees

CALCULATION OF FILING FEE TABLES

F-3

Radiopharm Theranostics Limited

Table 1: Newly Registered and Carry Forward Securities


Line Item Type	Security Type	Security Class Title	Notes	Fee Calculation Rule	Amount Registered	Proposed Maximum Offering Price Per Unit		Maximum Aggregate Offering Price		Fee Rate	Amount of Registration Fee

Newly Registered Securities
Fees to be Paid	Equity	Ordinary shares issuable upon exercise of warrants	(1)	Other	403,718,400	$	0.0069	$	2,785,656.96	0.0001381	$	384.70

Total Offering Amounts:								$	2,785,656.96			384.70
Total Fees Previously Paid:												0.00
Total Fee Offsets:												0.00
Net Fee Due:											$	384.70

__________________________________________
Offering Note(s)

(1)

In the form of American Depositary Shares (as evidenced by American Depositary Receipts, each representing 300 ordinary shares) have been registered on a separate registration statement on Form F-6 (File No. 333-282042).

Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement includes an indeterminate number of additional shares that may be offered and sold to prevent dilution resulting from share splits, share dividends, recapitalizations or similar transactions.

The maximum aggregate offering price has been estimated solely for the purpose of determining the amount of registration fee in accordance with Rule 457(c) under the Securities Act of 1933. The proposed maximum offering price per share and the proposed maximum aggregate offering price are based on the average of the high and low sale prices of the registrant’s ADSs on the Nasdaq Capital Market on September 9, 2026, or $2.08, divided by 300 (to give effect to the 300:1 ratio of ordinary shares to ADSs).